PMID- 36012915
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220830
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 11
IP  - 16
DP  - 2022 Aug 10
TI  - Current Trends in Clinical Characteristics, Diagnosis, and Treatment of 
      Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam.
LID - 10.3390/jcm11164678 [doi]
LID - 4678
AB  - Polypoidal choroidal vasculopathy (PCV) is a common choroidal disease in the 
      Asian population including Vietnam and is characterized by subretinal red-orange 
      nodules, pigmented epithelium detachment, and massive subretinal hemorrhage. The 
      recent focus on PCV in Vietnam can be attributed to advancements in PCV diagnosis 
      and treatment. However, there is a scarcity of published literature and clinical 
      data on PCV in the Vietnamese population, highlighting a key knowledge gap in 
      this region. In order to address this gap, we gathered the opinions of 
      experienced clinicians and retinal experts in Vietnam and reviewed available 
      medical literature with the aim of: (i) providing an overview of PCV in the 
      Vietnamese population-in terms of epidemiology, clinical characteristics, and 
      management; (ii) tailoring international/national guidelines for the diagnosis 
      and management of PCV, in line with available resources and medical equipment in 
      Vietnam; and (iii) identifying gaps in clinical data in order to guide future PCV 
      research in Vietnam and other countries with similar clinical conditions. The 
      present review will enable healthcare providers and researchers to gain insight 
      into current clinical practices and the limitations of PCV management in Vietnam 
      and provide optimal and effective solutions.
FAU - Dat, Dang Tran
AU  - Dat DT
AUID- ORCID: 0000-0002-0813-6039
AD  - Outpatient Department, Vietnam National Eye Hospital, 85 Ba Trieu, Nguyen Du 
      Ward, Hai Ba Trung District, Hanoi 100000, Vietnam.
FAU - Hien, Nguyen Do Thi Ngoc
AU  - Hien NDTN
AD  - Department of Ophthalmology, Hanoi Medical University, 1 Ton That Tung Street, 
      Hanoi 100000, Vietnam.
FAU - Quan, Nguyen Nhu
AU  - Quan NN
AD  - Phuong Dong International Eye Center, 71 Ngo Thoi Nhiem Street, District 3, Ho 
      Chi Minh City 700000, Vietnam.
FAU - Tung, Mai Quoc
AU  - Tung MQ
AUID- ORCID: 0000-0002-1201-1829
AD  - Department of Ophthalmology, Hanoi Medical University, 1 Ton That Tung Street, 
      Hanoi 100000, Vietnam.
FAU - Tam, Hoang Chi
AU  - Tam HC
AD  - Ophthalmology and Refractive Surgery Department, FV Hospital, 6 Nguyen Luong Bang 
      Street, Phu My Hung, District 7, Ho Chi Minh City 700000, Vietnam.
FAU - Hung, Bui Viet
AU  - Hung BV
AD  - Vitreoretial Department, Vietnam National Eye Hospital, 85 Ba Trieu, Nguyen Du 
      Ward, Hai Ba Trung District, Hanoi 100000, Vietnam.
LA  - eng
GR  - NA/Bayer Vietnam/
PT  - Journal Article
PT  - Review
DEP - 20220810
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC9410352
OTO - NOTNLM
OT  - Vietnam
OT  - anti-VEGF
OT  - laser therapy
OT  - neovascular age-related macular degeneration
OT  - polypoidal choroidal vasculopathy
COIS- D.T.D. has received honoraria for scientific presentations from Bayer, Novartis, 
      Allergan, and Santen. N.N.Q. has received honoraria for scientific presentations 
      from Novartis, Bayer, Abbott, Allergan, Abbvie, Santen, Senju, Alcon, and Zeiss. 
      M.Q.T. has received honoraria for scientific presentations from Bayer, Novartis, 
      and Alcon. H.C.T. has received honoraria for scientific presentations from 
      Nidek-Vietcan, Bayer, Novartis, and Zeiss. B.V.H. has received honoraria for 
      scientific presentations from Bayer and Novartis. N.D.T.N.H. reports no conflict 
      of interest.
EDAT- 2022/08/27 06:00
MHDA- 2022/08/27 06:01
PMCR- 2022/08/10
CRDT- 2022/08/26 01:26
PHST- 2022/05/30 00:00 [received]
PHST- 2022/07/29 00:00 [revised]
PHST- 2022/08/03 00:00 [accepted]
PHST- 2022/08/26 01:26 [entrez]
PHST- 2022/08/27 06:00 [pubmed]
PHST- 2022/08/27 06:01 [medline]
PHST- 2022/08/10 00:00 [pmc-release]
AID - jcm11164678 [pii]
AID - jcm-11-04678 [pii]
AID - 10.3390/jcm11164678 [doi]
PST - epublish
SO  - J Clin Med. 2022 Aug 10;11(16):4678. doi: 10.3390/jcm11164678.